We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Japanese geneticists used CRISPR-Cas3 to delete long DNA segments in Duchenne muscular dystrophy. The method is suitable for 60% of patients. Details in the article.
